Antonio Rosato

14.0k citations
229 papers · 10.4k indexed · 5 hit papers · h-index 45

Impact in

  • Cell Biology top 0.2%
    • Hippo pathway signaling and YAP/TAZ
  • Oncology top 0.5%
    • Cancer-related Molecular Pathways
    • Cancer Cells and Metastasis

Papers in

    • Immunotherapy and Immune Responses 41
    • Immune Cell Function and Interaction 36
    • T-cell and B-cell Immunology 15
    • CAR-T cell therapy research 27
    • Cancer Immunotherapy and Biomarkers 15

Antonio Rosato

221 papers receiving 10.3k citations

Hit Papers

Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth 2015 · 840 citations
84020092026201420202505007501000

Peers

Antonio Rosato
Comparison fields: 5 of 142
  • Cell Biology 2.7k
  • Oncology 3.3k
  • Cancer Research 1.7k
  • Immunology 1.8k
  • Molecular Biology 5.6k
Replace Pan Zheng with:
Pan Zheng United States
Frans C. S. Ramaekers Netherlands
Steven F. Dowdy United States
Naoya Fujita Japan
Masahiko Kuroda Japan
Rolf Bjerkvig Norway
Xiu‐Wu Bian China
Kevin P. Claffey United States
Tannishtha Reya United States
Michael F. Olson United Kingdom
Antonio Rosato relative to Pan Zheng United States Pan Zheng's profile →
Citations per field
00.5×1.5×
Pan Zheng · 1×
Citations per year

Countries citing papers authored by Antonio Rosato

Since Specialization
Citations

This map shows the geographic impact of Antonio Rosato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Rosato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Rosato more than expected).

Fields of papers citing papers by Antonio Rosato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Rosato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Rosato. The network helps show where Antonio Rosato may publish in the future.

Co-authors

The 25 scholars most cited alongside Antonio Rosato, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Antonio Rosato Line = papers co-authored together Antonio Rosato links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20241
4 20241
5 20240
6 20241
7 20237
8 20234
9 20232
10 202343
11 20223
12 202216
13 20229
14 20223
15 201818
16 201643
17 201619
18 2013112
19 201211
20 200947

About Antonio Rosato

Antonio Rosato is a scholar working on Immunology, Oncology, Radiology, Nuclear Medicine and Imaging, Architecture and Molecular Biology, having authored 229 papers that have together received 10.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (41 papers), Immune Cell Function and Interaction (36 papers), CAR-T cell therapy research (27 papers), Radiopharmaceutical Chemistry and Applications (26 papers), Virus-based gene therapy research (16 papers), Cancer Immunotherapy and Biomarkers (15 papers), T-cell and B-cell Immunology (15 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). The work is most often cited by research in Cell Biology (2.7k citations), Oncology (3.3k citations), Cancer Research (1.7k citations), Immunology (1.8k citations) and Molecular Biology (5.6k citations). Antonio Rosato has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Stefano Piccolo, Michelangelo Cordenonsi, Silvio Bicciato, Sirio Dupont, Mattia Forcato, Luca Azzolin, Paola Zanovello, Francesca Zanconato, A. Parenti and Roberta Sommaggio. Their work appears in journals such as The Journal of Immunology, Cancers, Nature Cell Biology, Frontiers in Immunology and OncoImmunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026